Summary
Evidence Report/Technology Assessment: Number 41
Please Note: The evidence report this summary was
derived from has not been updated within the past 5 years and is
therefore no longer considered current. It is maintained for archival
purposes only.
Under its Evidence-based
Practice Program, the Agency for Healthcare Research and Quality
(AHRQ) is developing scientific information for other agencies and
organizations on which to base clinical guidelines, performance
measures, and other quality improvement tools. Contractor institutions
review all relevant scientific literature on assigned clinical care
topics and produce evidence reports and technology assessments,
conduct research on methodologies and the effectiveness of their
implementation, and participate in technical assistance activities.
Overview
The objective of this evidence report was to conduct
a search of the published literature on the use of Ayurvedic medicine/therapies
for the treatment of health conditions and, on the basis of that
search, to choose either a condition or a modality for a comprehensive
review. A broad search of Ayurvedic medicine/therapies showed that
there was sufficient literature to support a systematic review of
the use of Ayurvedic therapies for the treatment of diabetes. Diabetes
is a common illness, and many traditional medical systems have developed
strategies to treat this condition. The Ayurvedic therapy most commonly
used to treat diabetes was herbal therapy, which therefore became
the primary focus of this review. A small number of studies looking
at diet therapy were also found.
Empirical evidence of efficacy for the Ayurvedic treatment
of diabetes would be helpful to health care providers managing diabetic
patients and would be useful in identifying areas for future research.
The specific questions addressed in this project were:
- What Ayurvedic therapies have been reported in
the literature, for which conditions/body systems, and using what
kinds of research designs?
- What is the efficacy of Ayurvedic medicine/therapies
for the treatment of diabetes?
Reporting the Evidence
An initial broad search of the literature found 2,565
titles, of which 1,214 were judged to represent Ayurvedic therapies
that were neither veterinary nor agricultural in nature and thus
potentially relevant to our review. To answer our first research
question, these 1,214 titles were screened for subject, language,
body system/disease state, study population, and study design. To
answer our second research question, we further assessed the potentially
relevant articles, including literature received from India. Fifty-four
articles containing the results of 62 human clinical studies using
Ayurvedic therapy for diabetes were identified. These studies were
analyzed in detail to determine if evidence existed regarding the
efficacy of Ayurvedic therapy for diabetes.
Methodology
A panel of technical experts representing diverse
disciplines was established to advise us throughout the course of
our research. A number of databases were searched: MEDLINE®,
HealthSTAR, EMBASE®, Allied and Complementary Medicine™,
MANTIS™, BIOSIS Previews®, CAB HEALTH, and CINAHL®.
We used the MeSH terms "Ayurveda" or "Ayurvedic"
combined with the botanical names of 16 herbs commonly used in Ayurvedic
treatment. In addition, a strategy was developed to identify and
retrieve literature from India. This involved using an abstracting
service in India to identify potentially relevant literature.
There was no language restriction in the Western literature
search. The Indian search was limited to studies published in English
because we could not read studies in other languages and did not
have the resources to have them translated. Additional articles
were identified from supplemental searches that focused on the Ayurvedic
herbs most often used for diabetes, on review articles, and on citations
of articles. All titles, abstracts, and articles were reviewed by
two reviewers, and all disagreements were resolved by consensus.
Data were collected using screening forms that we
developed for this purpose. We analyzed the data regarding the general
characteristics of the Ayurveda literature and used this information
to select a topic for a focused review.
We then conducted a focused literature review using
the articles we had identified from the Western literature and abstracts
of articles published in India. We selected all articles identified
as studying Ayurvedic therapies for diabetes in either the initial
or the focused search. We identified 54 articles containing the
results of 62 studies in this manner. Because of the heterogeneity
of these studies, a meta-analysis was not possible. Approximately
one-third of the studies were subjected to further analysis in which
we calculated a common effect statistic. We also conducted a qualitative
analysis on these studies.
Findings
- The most common conditions or body systems
for which studies of Ayurvedic therapies have been published are:
- Diabetes mellitus.
- Liver/hepatitis.
- Infectious diseases.
- Hypercholesterolemia.
- Central nervous system disorders (dementia/depression).
- Cardiovascular diseases.
- The Ayurvedic therapy that was the most common
subject of published studies was herbal therapy. Almost no studies
were found on any other Ayurvedic modalities.
- No studies were found that tested Ayurveda as a
whole system or that tested multiple modalities for the same disease
state at the same time.
- A significant body of literature in English exists
in India; it can be identified, and a large portion of the studies
can be obtained with effort. However, even after extensive efforts,
a handful of English-language studies in India could not be found.
Studies in non-English languages also exist but were not reviewed.
- Significant heterogeneity exists in the studies
identified. More than 45 single herbs or combination herbal therapies
were tested. The study designs likewise were varied. The 54 articles
reported the results of 62 studies. Of these, 7 were randomized
controlled trials (RCTs), and 10 were controlled clinical trials
(CCTs). There were 38 case series, the most frequently used clinical
design, and 7 cohort studies.
- The most common single herbs studied were Gymnema
sylvestre, Coccinia indica, fenugreek (Trigonella
foenum-graecum), and Eugenia jambolana. A number
of herbal formulas were tested, but Ayush-82 and D-400 were the
two most often studied.
- There is evidence to suggest that the single herbs
Coccinia indica, holy basil, fenugreek, and Gymnema
sylvestre and the herbal formulas Ayush-82 and D-400 have
a glucose-lowering effect and deserve further study. Evidence
of effectiveness of several other herbs is less extensive (C.
tamala, Eugenia jambolana, and Momordica charantia).
Our review has identified a number of interesting
areas for future research. Basic scientific studies of Ayurvedic
medicine have not been rigorously pursued. There are currently few
RCTs and CCTs in the literature, which hinders the assessment of
efficacy. Future trials need to enroll an adequate number of subjects.
Interventions should be compared to placebo preparations, and care
should be taken to construct placebos that cannot be distinguished
from the trial drug.
The clinical trials of Ayurvedic therapies for diabetes
need to be better reported. The method of patient selection and
assignment to arms needs to be better described, and the reporting
of results should follow good statistical practice. In addition,
the trials need to be of sufficient length to determine a relevant
clinical effect.
It would also be useful to investigate the efficacy
of single-herb therapies versus the relatively complex Ayurvedic
formulas used. It is not clear from the currently available literature
if the formulas provide any additional benefit over single-herb
therapies.
Field studies to determine how Ayurvedic medicine
is used in real-life clinical practice should be conducted. The
interaction between botanicals and other Ayurvedic modalities (yoga,
for example) on diabetes could be assessed. The relationship between
Ayurvedic diagnosis and Western diagnosis needs to be established.
Furthermore, trials incorporating more sophisticated
diabetes research should be conducted. Studies evaluating the impact
of Ayurveda using more current methods of assessing diabetes are
also needed.
The full evidence report from which this summary was
taken was prepared for the Agency for Healthcare Research and Quality
by the Southern
California Evidence-based Practice Center under contract No.
290-97-0001. Print copies may be obtained free of charge from the
AHRQ Publications Clearinghouse by calling 1-800-358-9295. Requesters
should ask for Evidence Report/Technology Assessment No. 41, Ayurvedic
Interventions for Diabetes Mellitus: A Systematic Review (AHRQ
Publication No. 01-E040).
The Evidence Report is also online at the National
Library of Medicine Bookshelf.
AHRQ Publication Number 01-E039
Current as of June 2001
Ayurvedic Interventions for Diabetes Mellitus:
A Systematic Review. Summary, Evidence Report/Technology Assessment:
Number 41. AHRQ Publication No. 01-E039, June 2001. Agency for Healthcare
Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/epcsums/ayurvsum.htm
|